Results 251 to 260 of about 84,355 (327)

Advances of Microneedles for Cancer Diagnosis and Therapy

MedComm – Biomaterials and Applications, Volume 4, Issue 3, September 2025.
Schematic diagram of microneedle for cancer diagnosis and treatment. ABSTRACT As the global incidence of cancer continues to rise, the need for innovative and precisive alternatives to conventional diagnostic and therapeutic methods has become increasingly urgent.
Chunli Yang, Li Zhang, Siyi Wang, Angxi Zhou, Run Tian, Maya Xiang, Ya Ren, Yang Yu, Rong Li, Maling Gou   +9 more
wiley   +1 more source

Upadacitinib unmasks cutaneous T-cell lymphoma in atopic dermatitis. [PDF]

JAAD Case Rep
Bui TS, Turney KC, Moresi JM, Jampel RM.
europepmc   +1 more source

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

MedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi, Izuchukwu F. Okpalanwaka, Adenike Oyegbesan, Ebenezar Okoyeocha, Mariam Oladejo, Sikiru O. Imodoye   +5 more
wiley   +1 more source

Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene. [PDF]

Cancers (Basel)
Ikawa T, Yamazaki E, Amagai R, Kambayashi Y, Sekine M, Takahashi T, Asano Y, Fujimura T.   +7 more
europepmc   +1 more source

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun, Dan Huang, Huiling Zhang, Mingyuan Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li, Zhaogang Yang   +10 more
wiley   +1 more source

Role of Retinoids and Their Analogs in the Treatment of Cutaneous T-cell Lymphoma: A Systematic Review. [PDF]

Cureus
Ayuthu S, Chauhan YD, Mirza AA, Saad MZ, Bittla P, Paidimarri SP, Nath TS.   +6 more
europepmc   +1 more source

Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma. [PDF]

Cancers (Basel)
Cieslak C, Hain C, Rückert-Reed C, Busche T, Klages LJ, Schaper-Gerhardt K, Gutzmer R, Kalinowski J, Stadler R.   +8 more
europepmc   +1 more source

Ulcerated nodules in a sporotrichoid distribution. [PDF]

, 2019
de Feraudy, Sebastien, Elsensohn, Ashley N, Hosking, Anna-Marie, Kraus, Christina N, Shiu, Jessica, Smith, Janellen   +5 more
core  

Safety and Oncologic Outcomes of Endoscopic Endonasal Transcribriform Approach for Locally Advanced Sinonasal Malignancies

Head &Neck, Volume 47, Issue 8, Page 2348-2357, August 2025.
ABSTRACT Introduction The past two decades have seen a paradigm shift in the surgical treatment of sinonasal malignancies, moving from traditional open approaches to minimally invasive endoscopic techniques. Technological advancements have enabled the use of the endoscopic endonasal transcribriform approach (EETA) for tumors involving the anterior ...
Michel Khalaf, Héloïse De Kermadec, Juliette Hershkovitch, Odile Casiraghi, Gabriel Garcia, François Bidault, François‐Régis Ferrand, France Nguyen, Stéphane Temam, Pierre Blanchard, Damien Bresson, Antoine Moya Plana   +11 more
wiley   +1 more source

Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management. [PDF]

JAAD Case Rep
Blanchard G, Blanchard M, Bernard P, Doms J, Cortés B, Boulinguez S, Guenova E.   +6 more
europepmc   +1 more source